 |
|
Introductory Remarks
Louis G. Welt, MD
Arch Intern Med. 1970;126(5):773.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
I am truly pleased to have had the opportunity to help develop the program for this symposium. Let me emphasize, however, that G. Donald Whedon, MD, Benjamin Burton, PhD, Keatha Krueger, PhD, Victoria Ragin, Henry R Black, MD, and his colleagues have done all of the hard work to make this possible. We are especially indebted to our colleagues from abroad who came a long distance to help make this endeavor a success; especially Carmelo Giordano, MD, Sergio Giovannetti, MD, R. Kluthe, MD, E. Kinsey M. Smith, MD, and Douglas A. K. Black, MD.
None of us who have been involved in this program have any notion that you will leave these communications with the knowledge of what the uremic toxins are, their source, their size, or their composition. Nor have we the confidence that we are necessarily looking at these problems with the proper perspective, the most appropriate conceptual
. . . [Full Text PDF of this Article]
Author Affiliations
Chapel Hill, NC
From the Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC.
Footnotes
Received for publication June 23, 1970; accepted July 8.
Read before the session entitled "Organ System Involvement in Uremia" (Louis G. Welt, MD, chairman) of the Symposium on Uremic Toxins sponsored by the National Institute of Arthritis and Metabolic Diseases, Monterey, Calif, March 18,1970.
Reprint requests to Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill, NC 27504.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
